Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 152

1.

The SINS trial: a randomised controlled trial of excisional surgery versus imiquimod 5% cream for nodular and superficial basal cell carcinoma.

Ozolins M, Williams HC, Armstrong SJ, Bath-Hextall FJ.

Trials. 2010 Apr 21;11:42. doi: 10.1186/1745-6215-11-42.

PMID:
20409337
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial.

Bath-Hextall F, Ozolins M, Armstrong SJ, Colver GB, Perkins W, Miller PS, Williams HC; Surgery versus Imiquimod for Nodular Superficial basal cell carcinoma (SINS) study group.

Lancet Oncol. 2014 Jan;15(1):96-105. doi: 10.1016/S1470-2045(13)70530-8. Epub 2013 Dec 11.

PMID:
24332516
[PubMed - indexed for MEDLINE]
Free Article
3.

What determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs imiquimod? A discrete choice experiment survey from the SINS trial.

Tinelli M, Ozolins M, Bath-Hextall F, Williams HC.

BMC Dermatol. 2012 Oct 4;12:19. doi: 10.1186/1471-5945-12-19.

PMID:
23035730
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study.

van der Geer S, Martens J, van Roij J, Brand E, Ostertag JU, Verhaegh ME, Neumann HA, Krekels GA.

Br J Dermatol. 2012 Jul;167(1):110-5. doi: 10.1111/j.1365-2133.2012.10924.x. Epub 2012 May 21.

PMID:
22385074
[PubMed - indexed for MEDLINE]
5.

Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.

Arits AH, Mosterd K, Essers BA, Spoorenberg E, Sommer A, De Rooij MJ, van Pelt HP, Quaedvlieg PJ, Krekels GA, van Neer PA, Rijzewijk JJ, van Geest AJ, Steijlen PM, Nelemans PJ, Kelleners-Smeets NW.

Lancet Oncol. 2013 Jun;14(7):647-54. doi: 10.1016/S1470-2045(13)70143-8. Epub 2013 May 15.

PMID:
23683751
[PubMed - indexed for MEDLINE]
6.

Two-year interim results from a 5-year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeks.

Quirk C, Gebauer K, Owens M, Stampone P.

Australas J Dermatol. 2006 Nov;47(4):258-65.

PMID:
17034468
[PubMed - indexed for MEDLINE]
7.

Treatment of cutaneous tumors with topical 5% imiquimod cream.

Alessi SS, Sanches JA, Oliveira WR, Messina MC, Pimentel ER, Festa Neto C.

Clinics (Sao Paulo). 2009;64(10):961-6. doi: 10.1590/S1807-59322009001000005.

PMID:
19841702
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe.

Schulze HJ, Cribier B, Requena L, Reifenberger J, Ferrándiz C, Garcia Diez A, Tebbs V, McRae S.

Br J Dermatol. 2005 May;152(5):939-47.

PMID:
15888150
[PubMed - indexed for MEDLINE]
9.

Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma.

Vidal D, Matías-Guiu X, Alomar A.

Clin Exp Dermatol. 2004 Sep;29(5):518-25.

PMID:
15347339
[PubMed - indexed for MEDLINE]
10.

Cost-effectiveness of treatment of superficial basal cell carcinoma: surgical excision vs. imiquimod 5% cream.

Vanaclocha F, Daudén E, Badía X, Guillén C, Conejo-Mir JS, Sainz de Los Terreros M, Hamel L, Llorens MA; HEIS Study Group.

Br J Dermatol. 2007 Apr;156(4):769-71. Epub 2007 Jan 30. No abstract available.

PMID:
17263811
[PubMed - indexed for MEDLINE]
11.

Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion.

Sterry W, Ruzicka T, Herrera E, Takwale A, Bichel J, Andres K, Ding L, Thissen MR.

Br J Dermatol. 2002 Dec;147(6):1227-36.

PMID:
12452875
[PubMed - indexed for MEDLINE]
12.

A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma.

Eigentler TK, Kamin A, Weide BM, Breuninger H, Caroli UM, Möhrle M, Radny P, Garbe C.

J Am Acad Dermatol. 2007 Oct;57(4):616-21. Epub 2007 Jul 3.

PMID:
17610993
[PubMed - indexed for MEDLINE]
13.

Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study in Europe.

Gollnick H, Barona CG, Frank RG, Ruzicka T, Megahed M, Tebbs V, Owens M, Stampone P.

Eur J Dermatol. 2005 Sep-Oct;15(5):374-81.

PMID:
16172048
[PubMed - indexed for MEDLINE]
14.

Use of 5% imiquimod cream in the treatment of facial basal cell carcinoma: a 3-year retrospective follow-up study.

Vun Y, Siller G.

Australas J Dermatol. 2006 Aug;47(3):169-71.

PMID:
16866996
[PubMed - indexed for MEDLINE]
15.

Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage.

Neville JA, Williford PM, Jorizzo JL.

J Drugs Dermatol. 2007 Sep;6(9):910-4.

PMID:
17941362
[PubMed - indexed for MEDLINE]
16.

5% imiquimod cream and reflectance-mode confocal microscopy as adjunct modalities to Mohs micrographic surgery for treatment of basal cell carcinoma.

Torres A, Niemeyer A, Berkes B, Marra D, Schanbacher C, González S, Owens M, Morgan B.

Dermatol Surg. 2004 Dec;30(12 Pt 1):1462-9.

PMID:
15606733
[PubMed - indexed for MEDLINE]
17.

Confirmation of histological clearance of superficial basal cell carcinoma with multiple serial sectioning and Mohs' micrographic surgery following treatment with imiquimod 5% cream.

Ezughah FI, Affleck AG, Evans A, Ibbotson SH, Fleming CJ.

J Dermatolog Treat. 2008;19(3):156-8. doi: 10.1080/09546630701759603.

PMID:
18569271
[PubMed - indexed for MEDLINE]
18.

Efficacy and tolerability of imiquimod 5% cream to treat periocular basal cell carcinomas.

Garcia-Martin E, Idoipe M, Gil LM, Pueyo V, Alfaro J, Pablo LE, Zubiri ML, Fernandez J.

J Ocul Pharmacol Ther. 2010 Aug;26(4):373-9. doi: 10.1089/jop.2010.0030.

PMID:
20698800
[PubMed - indexed for MEDLINE]
19.

Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year study.

Quirk C, Gebauer K, De'Ambrosis B, Slade HB, Meng TC.

Cutis. 2010 Jun;85(6):318-24.

PMID:
20666194
[PubMed - indexed for MEDLINE]
20.

Imiquimod 5% cream for the treatment of periocular Basal cell carcinoma.

Carneiro RC, de Macedo EM, Matayoshi S.

Ophthal Plast Reconstr Surg. 2010 Mar-Apr;26(2):100-2. doi: 10.1097/IOP.0b013e3181b8dd71.

PMID:
20305508
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk